---
kind: "section"
citation: "42 U.S.C. § 285b–7c"
title: "42"
title_heading: "The Public Health and Welfare"
number: "285b–7c"
heading: "Tuberculosis"
release: "119-102"
date: "2026-07-12"
url: "https://uscodex.org/usc/42/285b-7c"
units:
  - "Chapter 6A — Public Health Service"
  - "Subchapter III — National Research Institutes"
  - "Part C — Specific Provisions Respecting National Research Institutes"
  - "Subpart 2 — national heart, lung, and blood institute"
---

# §285b–7c. Tuberculosis

- (a) **In general—** The [Director](/usc/42/11851.md?p=5) of the National Institutes of Health may expand, intensify, and coordinate research and development and related activities of the Institutes with respect to tuberculosis including activities toward the goal of eliminating such disease.
- (b) **Certain activities—** Activities under [subsection (a)](#a) may include—
  - (1) enhancing basic and [clinical research](/usc/42/284d.md?p=b) on tuberculosis, including [drug](/usc/42/11851.md?p=4) resistant tuberculosis;
  - (2) expanding research on the relationship between such disease and the human immunodeficiency virus; and
  - (3) developing new tools for the elimination of tuberculosis, including public health interventions and methods to enhance detection and response to outbreaks of tuberculosis, including multidrug resistant tuberculosis.

## Source credit

(July 1, 1944, ch. 373, title IV, § 424C, as added Pub. L. 110–392, title II, § 201, Oct. 13, 2008, 122 Stat. 4201.)